The efficacy of an aromatic retinoid, Tigason (etretinate), in the treatment of Darier's disease
- 1 June 1981
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 104 (6) , 675-679
- https://doi.org/10.1111/j.1365-2133.1981.tb00754.x
Abstract
Eighteen patients with Darier's disease were treated for at least 3 months with the oral aromatic retinoid Tigason (etretinate, Ro 10‐9359). Seventeen of the 18 patients improved but adverse effects were seen in all patients, and were particularly severe in 6. No haematological or biochemical abnormalities were detected during treatment. We conclude that Tigason is an important advance in the treatment of Darier's disease but adverse effects restrict its use in some patients.This publication has 9 references indexed in Scilit:
- Effect of Systemic Ro 10-9359 Treatment on Immunological Parameters in Darier’s DiseasePublished by Springer Nature ,1981
- Ro 10-9359 Retinoid Inhibits Both in vitro Epidermal Cell Proliferation and DifferentiationPublished by Springer Nature ,1981
- Effects of Oral Retinoid on Dermal Components in Human and Animal SkinPublished by Springer Nature ,1981
- Light and Electron Microscopic Changes of Human Epidermis Under Oral Retinoid TreatmentPublished by Springer Nature ,1981
- Darier's disease: an immunologic studyArchives of Dermatology, 1978
- Oral treatment of keratosis follicularis with a new aromatic retinoidArchives of Dermatology, 1978
- Oral Administration of RetinoidsDermatology, 1978
- THERAPEUTICS XVI.British Journal of Dermatology, 1971
- Effect of Vitamin A on Epithelial Cells of SkinArchives of Dermatology, 1963